Correlation Between Niraj Ispat and Emcure Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Niraj Ispat and Emcure Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Niraj Ispat and Emcure Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Niraj Ispat Industries and Emcure Pharmaceuticals, you can compare the effects of market volatilities on Niraj Ispat and Emcure Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Niraj Ispat with a short position of Emcure Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Niraj Ispat and Emcure Pharmaceuticals.

Diversification Opportunities for Niraj Ispat and Emcure Pharmaceuticals

-0.32

Correlation Coefficient

Niraj Ispat  Emcure Pharmaceuticals

Very good diversification

The 3 months correlation between Niraj and Emcure is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Niraj Ispat Industries and Emcure Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emcure Pharmaceuticals and Niraj Ispat is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Niraj Ispat Industries are associated (or correlated) with Emcure Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emcure Pharmaceuticals has no effect on the direction of Niraj Ispat i.e., Niraj Ispat and Emcure Pharmaceuticals go up and down completely randomly.

Pair Corralation between Niraj Ispat and Emcure Pharmaceuticals

Assuming the 90 days trading horizon Niraj Ispat Industries is expected to generate 1.6 times more return on investment than Emcure Pharmaceuticals. However, Niraj Ispat is 1.6 times more volatile than Emcure Pharmaceuticals. It trades about 0.3 of its potential returns per unit of risk. Emcure Pharmaceuticals is currently generating about 0.12 per unit of risk. If you would invest  21,442  in Niraj Ispat Industries on September 27, 2024 and sell it today you would earn a total of  3,076  from holding Niraj Ispat Industries or generate 14.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Niraj Ispat Industries  vs.  Emcure Pharmaceuticals

Niraj Ispat Industries

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Niraj Ispat Industries are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Niraj Ispat unveiled solid returns over the last few months and may actually be approaching a breakup point.

Emcure Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Emcure Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Emcure Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Niraj Ispat and Emcure Pharmaceuticals

The main advantage of trading using opposite Niraj Ispat and Emcure Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Niraj Ispat position performs unexpectedly, Emcure Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emcure Pharmaceuticals will offset losses from the drop in Emcure Pharmaceuticals' long position.

The idea behind Niraj Ispat Industries and Emcure Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.